ClinicalTrials.Veeva

Menu

Intrinsic Periodic Pattern of Breathing (PERHYP1)

A

Association pour la Recherche en Physiologie de l'Environnement

Status

Unknown

Conditions

Normoxia
Hypercapnia
Hyperoxia
Hypoxia

Study type

Observational

Funder types

Other

Identifiers

NCT02201875
PERHYP1

Details and patient eligibility

About

We made a fortuitous observation of periodic breathing in a healthy subject coming to our outpatient mountain medicine consultation at Avicenne hospital in Bobigny (France). During this consultation, subjects perform a hypoxia exercise test, which allows a good prediction of their risk factors for severe high altitude illnesses. Surprisingly, breath-by-breath recording of the ventilation signal showed a periodic breathing pattern, which increased when the subject started to exercise in hypoxic conditions and was maintained during normoxic exercise.

Therefore, our objective was to confirm this observation in a retrospective study led in 82 subjects who passed this test. We tested the hypothesis that subjects with a brisk ventilatory response to hypoxia might show a more pronounced periodic pattern of ventilation, due to a higher gain of the chemoreceptor feedback loop. Then, our objective is to investigate the mechanisms involved in the periodic pattern in healthy subjects, as a function of exercise intensity, altitude intensity, role of peripheral and central chemoreceptors to O2 and CO2. Finally, we want to investigate the possible role of this ventilatory instability in patients with obstructive or central apneas.

Full description

In a preliminary study, among the population coming to the outpatient consultation of mountain medicine at Avicenne hospital in 2012, 82 subjects (38 females and 44 males) were randomly selected and separated in two groups of 41 high and 41 low responders to hypoxia according to the median value of the hypoxic ventilatory response to hypoxia at exercise (HVRe > or < 0.84 L/min/kg) derived from the hypoxic exercise test (inspired fraction of O2: 0.115, exercise intensity of 30% of maximal aerobic power), as previously described.

The hypoxic exercise test consists in 4 successive phases of 3 to 4 minutes each with the following sequence: rest in normoxia (RN), rest in hypoxia (RH), exercise in hypoxia (EH) and exercise in normoxia (EN). Minute ventilation ( E, L.min-1) is measured through a metabograph (Vmax Encore, SensorMedics, Yorba Linda, CA). Pulse O2 saturation (SpO2, %) is measured by transcutaneous oximetry (Nellcor N-595, Nellcor, Pleasanton, CA) on a pre-warmed ear lobe. End tidal PCO2 (PETCO2) is measured by infrared thermopile (Vmax Encore, SensorMedics, Yorba Linda, CA). During the whole test, VE, SpO2 and PETCO2 were recorded breath-by-breath. Continuous blood pressure is measured by a Finapres system. Data are transferred to a computer for further spectrum analysis. A Fast Fourier Transform (FFT) is then applied to the ventilation signal in sequences of 128 points in each phase of the test. This method will allow us to detect the presence of peaks in the frequency domain of the ventilation signal. Two main parameters are derived from the FFT: the frequency in hertz (or period in seconds) of the larger peak and its power estimated as the area under the peak at ± 0.02 Hz around the peak (in L2.s-2).

The main study will be designed in order to unravel the mechanisms and role of these oscillations in ventilation. An overall population of 90 healthy subjects and 30 patients will be included in the study.

Step 1. Effect of exercise intensity.

Step 2. Effect of altitude level.

Step 3. Effect of the stimulation of central chemoreceptors by acetazolamide.

Step 4. Effect of inhibiting the peripheral chemoreceptors by hyperoxia.

Step 5. Effect of inhibiting the peripheral chemoreceptors by hyperoxia and stimulating the central chemoreceptors by hypercapnia.

Step 6. Evaluating the presence of these oscillations in patients with sleep apneas.

Step 7. Evaluating the presence of these oscillations in patients with cardiac failure.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • depending on the group: see definition of groups

Exclusion criteria

  • BMI > 30
  • history of severe cardiac arrhythmia
  • pulmonary hypertension
  • history of coronary disease

Trial design

120 participants in 3 patient groups

Healthy subjects
Description:
male, aged 18-65 moderately trained healthy, no treatment
obstructive sleep apneas
Description:
patients with apnea/hypopnea index \> 15 BMI \< 30 Age \< 50 yrs
cardiac failure
Description:
NYHA class I to III ejection fraction \< 40% age \< 65 yrs BMI \< 30

Trial contacts and locations

1

Loading...

Central trial contact

Jean-Paul Richalet, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems